Relative contribution of target gene mutation and efflux to varying quinolone resistance in Irish Campylobacter isolates

被引:21
作者
Corcoran, D
Quinn, T
Cotter, L
Fanning, S [1 ]
机构
[1] Univ Coll Dublin, Ctr Food Safety, Sch Agr Food Sci & Vet Med, Dublin 4, Ireland
[2] Cork Inst Technol, Mol Diagnost Unit, Cork, Ireland
关键词
Campylobacter; gyrA mutation; efflux pumps; efflux pump inhibitor Phe-Arg-beta-Naphthylamide;
D O I
10.1016/j.femsle.2005.09.019
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The contribution of target gene mutations and active efflux to varying levels of quinolone resistance in Irish Campylobacter isolates was studied. The Thr-86-Ile modification of GyrA did not correlate with the level of quinolone resistance. The efflux pump inhibitor Phe-Arg-beta-Naphthylamide (PA beta N) had no effect on the MICs to ciprofloxacin. In contrast, a PA beta N sensitive efflux system contributed to the low-level nalixidic acid resistance phenotype. The lack of effect of PA beta N in high-level resistant nalidixic isolates may be attributable to mutations identified in the CmeB efflux pump of these isolates. PA beta N may have limited diagnostic value in the assessment of the contribution of efflux pump activity to ciprofloxacin resistance in Campylobacter. (c) 2005 Federation of European Microbiological Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:39 / 46
页数:8
相关论文
共 39 条
[31]   Evidence for multiple-antibiotic resistance in Campylobacter jejuni not mediated by CmeB or CmeF [J].
Pumbwe, L ;
Randall, LP ;
Woodward, MJ ;
Piddock, LJV .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (04) :1289-1293
[32]   Expression of the efflux pump genes cmeB, cmeF and the porin gene porA in multiple-antibiotic-resistant Campylobacter jejuni [J].
Pumbwe, L ;
Randall, LP ;
Woodward, MJ ;
Piddock, LJV .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (02) :341-347
[33]   Identification and molecular characterisation of CmeB, a Campylobacter jejuni multidrug efflux pump [J].
Pumbwe, L ;
Piddock, LJV .
FEMS MICROBIOLOGY LETTERS, 2002, 206 (02) :185-189
[34]   Effect of an efflux pump inhibitor on the MIC of nalidixic acid for Acinetobacter baumannii and Stenotrophomonas maltophilia clinical isolates [J].
Ribera, A ;
Ruiz, J ;
de Anta, MTJ ;
Vila, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (04) :697-U10
[35]   A double mutation in the gyrA gene is necessary to produce high levels of resistance to moxifloxacin in Campylobacter spp. clinical isolates [J].
Ruiz, J ;
Moreno, A ;
de Anta, MTJ ;
Vila, J .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 25 (06) :542-545
[36]   The efflux pump inhibitor Phe-Arg-β-naphthylamide does not abolish the activity of the Stenotrophomonas maltophilia SmeDEF multidrug efflux pump [J].
Sánchez, P ;
Le, U ;
Martínez, JL .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (04) :1042-1045
[37]   Structural basis of multiple drug-binding capacity of the AcrB multidrug efflux pump [J].
Yu, EW ;
McDermott, G ;
Zgurskaya, HI ;
Nikaido, H ;
Koshland, DE .
SCIENCE, 2003, 300 (5621) :976-980
[38]   Ciprofloxacin resistance in Campylobacter jejuni isolates:: Detection of gyrA resistance mutations by mismatch amplification mutation assay PCR and DNA sequence analysis [J].
Zirnstein, G ;
Li, Y ;
Swaminathan, B ;
Angulo, F .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (10) :3276-3280
[39]   Characterization of gyrA mutations associated with fluoroquinolone resistance in Campylobacter coli by DNA sequence analysis and MAMA PCR [J].
Zirnstein, G ;
Helsel, L ;
Li, Y ;
Swaminathan, B ;
Besser, J .
FEMS MICROBIOLOGY LETTERS, 2000, 190 (01) :1-7